← Back to Clinical Trials
Recruiting NCT07854119

NCT07854119 Kendall Exercises With and Without Positional Release Therapy in Upper Crossed Syndrome

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07854119
Status Recruiting
Phase —
Sponsor Riphah International University
Condition Upper Cross Syndrome
Study Type INTERVENTIONAL
Enrollment 48 participants
Start Date 2026-06-01
Primary Completion 2026-11-01

Eligibility & Interventions

Sex All sexes
Min Age 20 Years
Max Age 40 Years
Study Type INTERVENTIONAL
Interventions
Kendall Exercises with Positional Release TherapyKendall Exercises

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 48 participants in total. It began in 2026-06-01 with a primary completion date of 2026-11-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Upper Cross Syndrome (UCS) is a prevalent musculoskeletal disorder characterized by a specific pattern of muscular imbalance and postural dysfunction. This condition arises from prolonged poor posture. The resulting imbalance often manifests as visible postural changes, including rounded shoulders, forward head posture, and increased thoracic kyphosis. UCS is characterized by tightness and weakness of the neck, shoulders, and upper back muscles that cross between the dorsal and the ventral sides of the body. Postural abnormalities associated with UCS include a forward head posture (FHP), cervical lordosis, thoracic hyper kyphosis, protracted and elevated shoulders (round shoulders), and scapular winging with increased internal rotation and abduction. In UCS, neck and chest muscles, such as the sternocleidomastoid (SCM), levator scapulae, Pectoralis major and minor, Scalenes, and Upper Trapezius (UT), are tightened or shortened, whereas muscles of the neck and posterior upper back, such as the Deep Neck Flexors (DNFs), Serratus Anterior (SA), Rhomboids, Middle Trapezius (MT), and Lower Trapezius (LT), are weakened, stretched, and restrained. Opposite-group muscle imbalances in UCS bring postural disturbances, misalignments in the upper limbs, and atlanto-occipital, cervicothoracic, and glenohumeral joint dysfunction. The muscular imbalances may also lead to various musculoskeletal symptoms, such as headaches, neck pain, chest pain, upper back pain, tingling in the upper arms, or a limited range of motion in the neck or shoulders. The alteration in scapula muscles in UCS affects the movement of the scapula, which acts as a bridge and provides mobility and stability to the shoulders and neck. A proper posture is necessary for optimal functional performance in daily activities. The awkward positions put constant pressure on the joints, and degenerative changes in joints progress rapidly when exposed to sustained pressure, causing muscle imbalances and pain. If a muscle imbalance continues and progresses, this may lead to altered movement patterns and joint damage, creating further dysfunction. The main risk factor for developing UCS is maintaining an abnormal posture for a prolonged duration. Some daily activities that involve bad postures are often occupation-related. Repetitive tasks or continuous work for long hours can aggravate postural deviations. For example, patients with improper postures are more prone to musculoskeletal injuries after handling or lifting heavy objects than others with a proper posture. Musculoskeletal pain, most commonly neck pain, may present as the main symptom of UCS. Musculoskeletal pain may increase in relation to standing continuously or improperly sitting for long hours.

Eligibility Criteria

Inclusion Criteria: * Age 20 and 40 years. * Both Male and Female. * Clinical diagnosis of Upper Crossed Syndrome (Pectoralis major contracture test, Pectoralis minor contracture test, Upper trapezius muscle length test, Lower and Middle trapezius weakness tests will be done). * Forward Head Posture (Craniovertebral angle (CVA) ≤ 48°). * Numeric Pain Rating Scale (NPRS) score of ≥ 4). * Neck pain for more than 4 weeks but less than 6 months NDI. Exclusion Criteria: * History of cervical spine trauma, fractures, or surgery * Systemic musculoskeletal disorders * Spinal Deformities * Ongoing physiotherapy or chiropractic treatment * Severe scoliosis or spinal deformities

Contact & Investigator

Central Contact

Syed Shakil ur Rehman, PhD Physical Therapy

✉ shakil.urrehman@riphah.edu.pk

📞 +92 320 786661

Principal Investigator

Syed Shakil ur Rehman, PhD

PRINCIPAL INVESTIGATOR

Riphah International University

Frequently Asked Questions

Who can join the NCT07854119 clinical trial?

This trial is open to participants of all sexes, aged 20 Years or older, up to 40 Years, studying Upper Cross Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07854119 currently recruiting?

Yes, NCT07854119 is actively recruiting participants. Contact the research team at shakil.urrehman@riphah.edu.pk for enrollment information.

Where is the NCT07854119 trial being conducted?

This trial is being conducted at Lahore, Pakistan, Lahore, Pakistan.

Who is sponsoring the NCT07854119 clinical trial?

NCT07854119 is sponsored by Riphah International University. The principal investigator is Syed Shakil ur Rehman, PhD at Riphah International University. The trial plans to enroll 48 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology